182 related articles for article (PubMed ID: 19444130)
1. Individual pathogens, pathogen burden and markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.
Szklo M; Ding J; Tsai MY; Cushman M; Polak JF; Lima J; Barr RG; Sharrett AR
J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):747-51. PubMed ID: 19444130
[TBL] [Abstract][Full Text] [Related]
2. Socioeconomic and psychosocial gradients in cardiovascular pathogen burden and immune response: the multi-ethnic study of atherosclerosis.
Aiello AE; Diez-Roux A; Noone AM; Ranjit N; Cushman M; Tsai MY; Szklo M
Brain Behav Immun; 2009 Jul; 23(5):663-71. PubMed ID: 19150399
[TBL] [Abstract][Full Text] [Related]
3. Serological evidence of infections and Type 2 diabetes: the MultiEthnic Study of Atherosclerosis.
Lutsey PL; Pankow JS; Bertoni AG; Szklo M; Folsom AR
Diabet Med; 2009 Feb; 26(2):149-52. PubMed ID: 19236617
[TBL] [Abstract][Full Text] [Related]
4. The impact of pathogen burden on leukocyte telomere length in the Multi-Ethnic Study of Atherosclerosis.
Aiello AE; Jayabalasingham B; Simanek AM; Diez-Roux A; Feinstein L; Meier HCS; Needham BL; Dowd JB
Epidemiol Infect; 2017 Oct; 145(14):3076-3084. PubMed ID: 28879822
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between infectious burden and carotid atherosclerosis in Japanese patients.
Hagiwara N; Toyoda K; Inoue T; Shimada H; Ibayashi S; Iida M; Okada Y
J Stroke Cerebrovasc Dis; 2007; 16(4):145-52. PubMed ID: 17689410
[TBL] [Abstract][Full Text] [Related]
6. Impact of infectious burden on progression of carotid atherosclerosis.
Espinola-Klein C; Rupprecht HJ; Blankenberg S; Bickel C; Kopp H; Victor A; Hafner G; Prellwitz W; Schlumberger W; Meyer J
Stroke; 2002 Nov; 33(11):2581-6. PubMed ID: 12411646
[TBL] [Abstract][Full Text] [Related]
7. Serum and peripheral blood mononuclear cells infectious burden: correlation to inflammation and atherosclerosis in haemodialysis patients.
Tsirpanlis G; Chatzipanagiotou S; Ioannidis A; Boufidou F; Moutafis S; Nicolaou C
Nephrology (Carlton); 2005 Jun; 10(3):256-63. PubMed ID: 15958038
[TBL] [Abstract][Full Text] [Related]
8. The prospective association of Chlamydia pneumoniae and four other pathogens with development of coronary artery calcium: the multi-ethnic study of atherosclerosis (MESA).
Laek B; Szklo M; McClelland RL; Ding J; Tsai MY; Bluemke DA; Tracy R; Matsushita K
Atherosclerosis; 2013 Oct; 230(2):268-74. PubMed ID: 24075755
[TBL] [Abstract][Full Text] [Related]
9. Unpacking the 'black box' of total pathogen burden: is number or type of pathogens most predictive of all-cause mortality in the United States?
Simanek AM; Dowd JB; Zajacova A; Aiello AE
Epidemiol Infect; 2015 Sep; 143(12):2624-34. PubMed ID: 25518978
[TBL] [Abstract][Full Text] [Related]
10. Absence of association between infectious agents and endothelial function in healthy young men.
Khairy P; Rinfret S; Tardif JC; Marchand R; Shapiro S; Brophy J; Dupuis J
Circulation; 2003 Apr; 107(15):1966-71. PubMed ID: 12681997
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and persistence of antibodies to herpes viruses, Chlamydia pneumoniae and Helicobacter pylori in Alaskan Eskimos: the GOCADAN Study.
Zhu J; Davidson M; Leinonen M; Saikku P; Gaydos CA; Canos DA; Gutman KA; Howard BV; Epstein SE;
Clin Microbiol Infect; 2006 Feb; 12(2):118-22. PubMed ID: 16441448
[TBL] [Abstract][Full Text] [Related]
12. Human cytomegalovirus seropositivity is associated with impaired vascular function.
Grahame-Clarke C; Chan NN; Andrew D; Ridgway GL; Betteridge DJ; Emery V; Colhoun HM; Vallance P
Circulation; 2003 Aug; 108(6):678-83. PubMed ID: 12900349
[TBL] [Abstract][Full Text] [Related]
13. High immunoglobulin A seropositivity for combined Chlamydia pneumoniae, Helicobacter pylori infection, and high-sensitivity C-reactive protein in coronary artery disease patients in India can serve as atherosclerotic marker.
Jha HC; Prasad J; Mittal A
Heart Vessels; 2008 Nov; 23(6):390-6. PubMed ID: 19037586
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Chlamydophila pneumoniae is higher in aorta and coronary artery than in carotid artery of coronary artery disease patients.
Jha HC; Srivastava P; Divya A; Prasad J; Mittal A
APMIS; 2009 Dec; 117(12):905-11. PubMed ID: 20078556
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of pathogen burden and risk of myocardial infarction or death.
Zhu J; Nieto FJ; Horne BD; Anderson JL; Muhlestein JB; Epstein SE
Circulation; 2001 Jan; 103(1):45-51. PubMed ID: 11136684
[TBL] [Abstract][Full Text] [Related]
16. Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
Smieja M; Gnarpe J; Lonn E; Gnarpe H; Olsson G; Yi Q; Dzavik V; McQueen M; Yusuf S;
Circulation; 2003 Jan; 107(2):251-7. PubMed ID: 12538424
[TBL] [Abstract][Full Text] [Related]
17. Statistical genetic analysis of serological measures of common, chronic infections in Alaska Native participants in the GOCADAN study.
Rubicz R; Zhu J; Laston S; Cole SA; Voruganti VS; Ebbesson SO; Howard BV; Maccluer JW; Davidson M; Umans JG; Comuzzie AG; Göring HH
Genet Epidemiol; 2013 Nov; 37(7):751-7. PubMed ID: 23798484
[TBL] [Abstract][Full Text] [Related]
18. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis.
Mayr M; Kiechl S; Willeit J; Wick G; Xu Q
Circulation; 2000 Aug; 102(8):833-9. PubMed ID: 10952949
[TBL] [Abstract][Full Text] [Related]
19. The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study.
Haider AW; Wilson PW; Larson MG; Evans JC; Michelson EL; Wolf PA; O'Donnell CJ; Levy D
J Am Coll Cardiol; 2002 Oct; 40(8):1408-13. PubMed ID: 12392829
[TBL] [Abstract][Full Text] [Related]
20. The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: the Persian Gulf Healthy Heart Study.
Nabipour I; Vahdat K; Jafari SM; Pazoki R; Sanjdideh Z
Cardiovasc Diabetol; 2006 Dec; 5():25. PubMed ID: 17140429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
